期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
Luteolin affects the EMT transformation and cell biological behavior of osteosarcoma U2OS cells via the PI3K/AKT/NF-κB signaling pathway
1
作者 Guo-Xin Qu Zhi-Hua Ji +2 位作者 Kun Fu Hua-Yi Qu Yue-Song Wu 《Journal of Hainan Medical University》 2019年第21期1-6,共6页
Objective:To investigate the effect of luteolin on the Epithelial-mesenchymal transition(EMT)of osteosarcoma cell line U2OS and its molecular mechanism by regulating phosphoinositide 3-kinase/protein kinase B/nuclear ... Objective:To investigate the effect of luteolin on the Epithelial-mesenchymal transition(EMT)of osteosarcoma cell line U2OS and its molecular mechanism by regulating phosphoinositide 3-kinase/protein kinase B/nuclear factor-kappa B(PI3K/AKT/NF-κB)signaling pathway.Methods:U2OS cells were treated in different concentrations(10,20 and 40μmol/L)of luteolin.MTT was used to detect the effect of luteolin on the proliferation of osteosarcoma U2OS cells.Transwell chamber assay was used to detect the influence of luteolin on migration of U2OS cells.qPCR was used to detect the influence of luteolin on the mRNA expression of Bax,Bcl-2 and Caspase-2 in U2OS cells.Western blot was used to observe the change of p-PI3K,p-AKT,p-IKK and NF-κB proteins.Immunofluorescence was used to detect the influence of luteolin on the protein expression of E-cadherin and vimentim.Results:Luteolin inhibited significantly the proliferation of U2OS cells(P<0.05)in a time-concentration-dependent manner.Luteolin inhibited significantly the migration of U2OS cells(P<0.05).After treatment with luteolin,the mRNA expression of Bax and Caspase-2 was increased significantly(P<0.05),but Bcl-2 was reduced significantly(P<0.05)in U2OS cells.The protein expression of p-PI3K,p-AKT,p-IKK,NF-κB,E-cadherin and vimentin was decreased significantly(P<0.05).Conclusions:Luteolin inhibits the proliferation,migration and EMT transformation of osteosarcoma U2OS cells,which may be related to the inhibition of PI3K/AKT/NF-κB signaling pathway. 展开更多
关键词 LUTEOLIN pi3k/akt/nf-κb signaling pathway OSTEOSARCOMA EMT TRANSFORMATION CELL biological behavior
下载PDF
Emerging agents that target signaling pathways to eradicate colorectal cancer stem cells 被引量:7
2
作者 Valdenizia R.Silva Luciano de S.Santos +2 位作者 Rosane B.Dias Claudio A.Quadros Daniel P.Bezerra 《Cancer Communications》 SCIE 2021年第12期1275-1313,共39页
Colorectal cancer(CRC)represents the third most commonly diagnosed cancer and the second leading cause of cancer death worldwide.The modern concept of cancer biology indicates that cancer is formed of a small populati... Colorectal cancer(CRC)represents the third most commonly diagnosed cancer and the second leading cause of cancer death worldwide.The modern concept of cancer biology indicates that cancer is formed of a small population of cells called cancer stem cells(CSCs),which present both pluripotency and self-renewal properties.These cells are considered responsible for the progression of the disease,recurrence and tumor resistance.Interestingly,some cell signaling pathways participate in CRC survival,proliferation,and selfrenewal properties,and most of them are dysregulated in CSCs,including the Wingless(Wnt)/β-catenin,Notch,Hedgehog,nuclear factor kappa B(NF-κB),Janus kinase/signal transducer and activator of transcription(JAK/STAT),peroxisome proliferator-activated receptor(PPAR),phosphatidyl-inositol-3-kinase/Akt/mechanistic target of rapamycin(PI3K/Akt/mTOR),and transforming growth factor-β(TGF-β)/Smad pathways.In this review,we summarize the strategies for eradicating CRC stem cells by modulating these dysregulated pathways,which will contribute to the study of potential therapeutic schemes,combining conventional drugs with CSC-targeting drugs,and allowing better cure rates in anti-CRC therapy. 展开更多
关键词 COLORECTAL cancer stem cells cell signaling Wnt/β-catenin pathway NOTCH HEDGEHOG nf-κb JAk/STAT signaling pi3k/akt/mTOR signaling targeted therapy
原文传递
麦角甾苷治疗对去卵巢大鼠骨质疏松症保护机制研究 被引量:4
3
作者 王海生 马涛 +1 位作者 张敏 陶周善 《中国骨质疏松杂志》 CAS CSCD 北大核心 2022年第3期341-346,共6页
目的探讨麦角甾苷(MJZG)治疗对去卵巢大鼠骨密度降低和骨量流失的潜在影响,并探索可能的机制。方法通过双侧去卵巢构建骨质疏松大鼠模型;随后将大鼠随机分为假手术组(Sham)、去卵巢组(OVX)以及麦角甾苷(MJZG),每组10只;其中MJZG组大鼠... 目的探讨麦角甾苷(MJZG)治疗对去卵巢大鼠骨密度降低和骨量流失的潜在影响,并探索可能的机制。方法通过双侧去卵巢构建骨质疏松大鼠模型;随后将大鼠随机分为假手术组(Sham)、去卵巢组(OVX)以及麦角甾苷(MJZG),每组10只;其中MJZG组大鼠接受麦角甾苷(100 mg/kg)治疗12周;待治疗截止时获取股骨标本和血液样品进一步检测股骨骨量、骨强度、骨代谢指标改变以及组织蛋白的表达。结果术后12周,与Sham组相比,OVX组的大鼠骨小梁微观参数和骨密度和骨矿物质含量以及骨强度显著降低;而MJZG组大鼠BMD、BV/TV、Tb.N、Tb.Th和Tb.Sp以及最大载荷和弹性模量较OVX组明显改善(P<0.05)。MJZG组大鼠血清BGP、ALP、TRACP-5b和DPD水平较OVX组明显降低,组间差异有统计学意义(P<0.05)。WB检测观察到,和OVX组比较,MJZG组的TRAF6、RANKL、NF-κB和NFAT2的蛋白水平表达下调(P<0.05),而PI3K、AKT和c-Fos上调(P<0.05)。结论MJZG可以通过抑制RANKL/TRAF6/NF-κB和激活PI3K/AKT防治去卵巢诱导的骨质疏松症。 展开更多
关键词 麦角甾苷 绝经后骨质疏松症 骨密度 rankl/traf6/nf-κbpi3k/akt信号通路
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部